JamesGerardKublinMD

Preventive Medicine • Seattle, WA

Public Health & General Preventive Medicine

Executive Director, HIV Vaccine Trials Network; Medical Director, Malaria Clinical Trials Center

Join to view full profile

Dr. Kublin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Kublin's full profile

Already have an account?

Office
1100 Fairview Ave N
Seattle, WA 98109
Phone+1 206-667-1970

Education & Training

Johns Hopkins Bloomberg School of Public HealthResidency, Public Health and General Preventive Medicine, 1996 - 1998
New York Medical College at St Vincent's Hospital and Medical Center of New YorkInternship, Transitional Year, 1988 - 1989
Georgetown University School of MedicineClass of 1988

Certifications & Licensure

WA State Medical License 2005 - 2026
MI State Medical License 1989 - 2014

Clinical Trials

Malaria Clinical Trials Center General Screening Start of enrollment: 2010 Jun 01
Completed
Validation of Diagnostics to Identify Glucose-6-phosphate Dehydrogenase Activity in the US Start of enrollment: 2019 May 13
Completed
Not Applicable

Publications & Presentations

PubMed

41 citations
A phase 1b randomized study of the safety and immunological responses to vaccination with H4:IC31, H56:IC31, and BCG revaccination in Mycobacterium tuberculosis-uninfe...
Linda-Gail Bekker, One B. Dintwe, Andrew Fiore-Gartland, Keren Middelkoop, Julia Hutter
Eclinicalmedicine. 2020-04-01
403 citations
Reemergence of Chloroquine-Sensitive Plasmodium falciparum Malaria after Cessation of Chloroquine Use in Malawi
James G. Kublin, Joseph F. Cortese, Eric Mbindo Njunju, Rabia A G Mukadam, Jack J. Wirima
The Journal of Infectious Diseases. 2003-06-15
140 citations
Safety and Comparative Immunogenicity of an HIV-1 DNA Vaccine in Combination with Plasmid Interleukin 12 and Impact of Intramuscular Electroporation for Delivery
Spyros A. Kalams, Scott D. Parker, Marnie Elizaga, Barbara Metch, Srilatha Edupuganti
The Journal of Infectious Diseases. 2013-09-01

Press Mentions

The COVID Vaccine Success Story as a Springboard for Future ResearchJanuary 24th, 2023
Coordination of COVID-19 Vaccine Clinical Trials Produces a ‘Treasure Trove’ of Data and a Model for the FutureJanuary 23rd, 2023
Highlights of Virtual Congressional Briefing: Understanding the Immune Response to COVID-19June 24th, 2021
Join now to see all